COVERED Immune Sub-Study
Study Purpose
The Immune Sub-Study was developed as a sub-protocol of the Canadian COVID-19 Vaccine Registry for Pregnant and Lactating Individuals (COVERED). The larger vaccine study aims to assess safety, effectiveness, and acceptability of COVID-19 vaccination in pregnant individuals. The Immune Sub-Study aims to enable a better understanding of the immune response of the COVID-19 vaccine generated during pregnancy by looking at maternal and infant blood samples, as well as breast milk.
Study Objectives
- To examine immune response to COVID-19 vaccination in pregnant individuals and their infants
- To measure IgG and IgA antibody levels in breastmilk samples
Study Eligibility
- Currently pregnant and scheduled to or intending to be vaccinated against COVID-19
- 19 years of age or older
- Able to communicate in English
- Registered to deliver at BC Women’s Hospital

Please contact covered.covid@ubc.ca for more information or questions about the Immune Sub-Study.
To learn more about the COVERED Vaccine Registry and to participate in the survey, CLICK HERE
